Basic info
Industry
biotechnology research
Sectors
Biotechnology
neoepitopes
tumor immunology
T cell receptor
TCR gene transfer
target selection
neoantigens
gene therapy
immunoncology
tumor antigens
adoptive T cell therapy
TCR generation
TCR characterization
cell therapy
cancer testis antigens
retroviral vectors
Date founded
2018
Funding rounds raised
Total raised
$110M
from 12 investors over 12 rounds
T
T-knife Therapeutics raised $110M on August 2, 2021
Investors: Andera Partners, CaaS Capital Management, Qatar Investment Authority, Sixty Degree Capital, EQT Life Sciences, Casdin Capital, LLC, Versant Ventures and RA Capital Management, L.P.
T
T-knife Therapeutics raised $78M on August 6, 2020
Investors: Versant Ventures, Andera Partners and RA Capital Management, L.P.
T
T-knife Therapeutics raised $9.1M on December 1, 2018
Investors: Andera Partners